Biocon Biologics said on Tuesday that the US Food and Drug Administration (US FDA) has approved the company's first-to-file application for Yesafili, a biosimilar drug for treating eye ailments.The company said the medicine is similar to the .
Biocon arm s copy of ophthalmology drug gets U S FDA nod thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.